It's crunch time for biotech projects started on a bet that the industry would shake off its multiyear malaise.

Here are three fantastic biotech stocks harnessing the power of AI that could make a great addition to your portfolio. The ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

News of the layoffs come just one day after the company reported a 5% year over year revenue increase — boosting revenue to ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...

Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Trinity Biotech ( ($TRIB) ) has shared an update. On February 6, 2025, Trinity Biotech announced significant improvements in its continuous ...